Stephen P. Fortmann

ORCID: 0000-0002-1327-9341
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Smoking Behavior and Cessation
  • Obesity, Physical Activity, Diet
  • Behavioral Health and Interventions
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Lipoproteins and Cardiovascular Health
  • Cardiovascular Health and Risk Factors
  • Nicotinic Acetylcholine Receptors Study
  • Nutritional Studies and Diet
  • Acute Myocardial Infarction Research
  • Cardiac Imaging and Diagnostics
  • Health disparities and outcomes
  • Vitamin C and Antioxidants Research
  • Health Promotion and Cardiovascular Prevention
  • Blood Pressure and Hypertension Studies
  • Health Systems, Economic Evaluations, Quality of Life
  • Diabetes Management and Research
  • Diabetes Treatment and Management
  • Obesity and Health Practices
  • Global Public Health Policies and Epidemiology
  • Metabolism, Diabetes, and Cancer
  • Physical Activity and Health
  • Cardiovascular Function and Risk Factors
  • Diabetes Management and Education
  • Folate and B Vitamins Research
  • Vitamin D Research Studies

Kaiser Permanente Center for Health Research
2016-2025

Kaiser Permanente
2006-2024

Group for the Analysis of Development
2023

Minneapolis Institute of Arts
2023

Milken Institute
2022

National Institutes of Health
2022

National Institute of Diabetes and Digestive and Kidney Diseases
2022

VA Puget Sound Health Care System
2022

Atlanta VA Medical Center
2022

Massachusetts General Hospital
2022

In 1998, the American Heart Association convened Prevention Conference V to examine strategies for identification of high-risk patients who need primary prevention. Among discussed was measurement markers inflammation.1 The concluded that “many these (including inflammatory markers) are not yet considered applicable routine risk assessment because of: (1) lack standardization, (2) consistency in epidemiological findings from prospective studies with endpoints, and (3) evidence novel marker...

10.1161/01.cir.0000052939.59093.45 article EN Circulation 2003-01-28
Kristian Thygesen Joseph S. Alpert Allan S. Jaffe Maarten L. Simoons Bernard R. Chaitman and 95 more Harvey D. White Kristian Thygesen Joseph S. Alpert Harvey D. White Allan S. Jaffe Hugo A. Katus Fred S. Apple Bertil Lindahl David A. Morrow Bernard R. Chaitman Peter Clemmensen Per Johanson Hanoch Hod Richard Underwood Jeroen J. Bax Robert O. Bonow Fausto J. Pinto Raymond J. Gibbons Keith A.A. Fox Dan Atar L. Kristin Newby Marcello Galvani Christian W. Hamm Barry F. Uretsky Philippe Gabríel Steg William Wijns Jean‐Pierre Bassand P Menasché Jan Ravkilde E. Magnus Ohman Elliott M. Antman Lars Wallentin Paul W. Armstrong Maarten L. Simoons James L. Januzzi Markku S. Nieminen Mihai Gheorghiade Gerasimos Filippatos Russell V. Luepker Stephen P. Fortmann Wayne D. Rosamond Daniel Levy David A. Wood Sidney C. Smith Dayi Hu J L López-Sendón Rose Marie Robertson Donald W. Weaver Michał Tendera Alfred A. Bové Alexander Parkhomenko Elena Vasilieva Shanthi Mendis Jeroen J. Bax Helmut Baumgartner Claudio Ceconi Verónica Dean Christi Deaton Robert Fagard Christian Funck‐Brentano David Hasdai Arno W. Hoes Paulus Kirchhof Juhani Knuuti Philippe Kolh Theresa A. McDonagh Bruno Moulin Bogdan A. Popescu Željko Reiner Udo Sechtem Per Anton Sirnes Michał Tendera Adam Torbicki Alec Vahanian Stephan Windecker João Morais Carlos Aguíar Wael Almahmeed Davíð O. Arnar Fabio Barili Kenneth D. Bloch Ann F. Bolger Hans Erik Bøtker Biykem Bozkurt Raffaele Bugiardini Christopher P. Cannon James A. de Lemos Franz R. Eberli Edgardo Escobar Mark A. Hlatky Stefan James Karl B. Kern David J. Moliterno Christian Mueller Aleksandar Nešković

10.1093/eurheartj/ehs184 article EN European Heart Journal 2012-08-24
Kristian Thygesen Joseph S. Alpert Allan S. Jaffe Maarten L. Simoons Bernard R. Chaitman and 95 more Harvey D. White Kristian Thygesen Joseph S. Alpert Harvey D. White Allan S. Jaffe Hugo A. Katus Fred S. Apple Bertil Lindahl David A. Morrow Bernard R. Chaitman Peter Clemmensen Per Johanson Hanoch Hod Richard Underwood Jeroen J. Bax Jeroen J Bonow Fausto J. Pinto Raymond J. Gibbons Keith A.A. Fox Dan Atar L. Kristin Newby Marcello Galvani Christian W. Hamm Barry F. Uretsky Philippe Gabríel Steg William Wijns Jean‐Pierre Bassand P Menasché Jan Ravkilde E. Magnus Ohman Elliott M. Antman Lars Wallentin Paul W. Armstrong Maarten L. Simoons James L. Januzzi Markku S. Nieminen Mihai Gheorghiade Gerasimos Filippatos Russell V. Luepker Stephen P. Fortmann Wayne D. Rosamond Daniel Levy David A. Wood Sidney C. Smith Dayi Hu J L López-Sendón Rose Marie Robertson Donald W. Weaver Michał Tendera Alfred A. Bové Alexander Parkhomenko Elena Vasilieva Shanthi Mendis Jeroen J. Bax Helmut Baumgartner Claudio Ceconi Verónica Dean Christi Deaton Robert Fagard Christian Funck‐Brentano David Hasdai Arno W. Hoes Paulus Kirchhof Juhani Knuuti Philippe Kolh Theresa A. McDonagh Bruno Moulin Bogdan A. Popescu Željko Reiner Udo Sechtem Per Anton Sirnes Michał Tendera Adam Torbicki Alec Vahanian Stephan Windecker João Morais Carlos Aguíar Wael Almahmeed Davíð O. Arnar Fabio Barili Kenneth D. Bloch Ann F. Bolger Hans Erik Bøtker Biykem Bozkurt Raffaele Bugiardini Christopher P. Cannon James A. de Lemos Franz R. Eberli Edgardo Escobar Mark A. Hlatky Stefan James Karl B. Kern David J. Moliterno Christian Mueller Aleksandar Nešković

10.1016/j.jacc.2012.08.001 article EN Journal of the American College of Cardiology 2012-09-05

BACKGROUND. Socioeconomic status (SES) is usually measured by determining education, income, occupation, or a composite of these dimensions. Although education the most commonly used measure SES in epidemiological studies, no investigators United States have conducted an empirical analysis quantifying relative impact each separate dimension on risk factors for disease. METHODS. Using data 2380 participants from Stanford Five-City Project (85% White, non-Hispanic), we examined independent...

10.2105/ajph.82.6.816 article EN American Journal of Public Health 1992-06-01

Previous measures of physical activity for epidemiologic studies were considered inadequate to meet the needs a community-based health education trial. Therefore, new methods quantifying habits communities developed which are practical large surveys, provide information on distribution in population, can detect changes over time, and be compared with other activity. Independent self-reports vigorous (at least 6 metabolic equivalents (METs) ), moderate (3-5 METs), total energy expenditure...

10.1093/oxfordjournals.aje.a113987 article EN American Journal of Epidemiology 1985-01-01

A workshop was held September 27 through 29, 1999, to address issues relating national trends in mortality and morbidity from cardiovascular diseases; the apparent slowing of declines levels risk factors for disparities diseases by race/ethnicity, socioeconomic status, geography; disease preventive treatment services; strategies efforts reduce overall among subpopulations. The conference concluded that coronary heart is still declining United States as a whole, although perhaps at slower...

10.1161/01.cir.102.25.3137 article EN Circulation 2000-12-19

We studied separately the influence of two methods for losing fat weight on levels plasma lipids and lipoproteins in overweight sedentary men — decreasing energy intake without increasing exercise (diet), expenditure altering (exercise, primarily running) a one-year randomized controlled trial. As compared with controls (n = 42), dieters 42) had significant loss total body (-7.8±0.9 kg [mean ±SE]), (-5.6±0.8 kg), lean (nonfat) (-2.1±0.5 kg) (P<0.001 each variable), exercisers 47) (-4.6±0.8...

10.1056/nejm198811033191801 article EN New England Journal of Medicine 1988-11-03

Obesity is a major influence on the development and course of cardiovascular diseases affects physical social functioning quality life. The importance effective interventions to reduce obesity related health risks has increased in recent decades because number adults children who are obese reached epidemic proportions. To prevent overweight throughout life course, population-based strategies that improve environmental contexts for healthful eating activity essential. Population-based...

10.1161/circulationaha.108.189702 article EN Circulation 2008-07-01

Objective: Previous reports have suggested that depression may lead to the development of cardiovascular disease through its association with metabolic syndrome; however, little is known about relationship between and syndrome. The aim this study was establish an syndrome in a nationally representative sample. Methods: Third National Health Nutrition Examination Survey population-based health survey noninstitutionalized US citizens completed 1988 1994. Three thousand one hundred eighty-six...

10.1097/01.psy.0000124755.91880.f4 article EN Psychosomatic Medicine 2004-05-01

Background— No studies have comprehensively examined the prevalence of dyslipidemia, a major risk factor for cardiovascular disease, among diverse racial/ethnic minority groups. The primary aim this study was to identify differences in dyslipidemia minorities including Asian Americans (Asian Indian, Chinese, Filipino, Japanese, Korean, or Vietnamese), Mexican Americans, and blacks compared with non-Hispanic whites. Methods Results— Using 3-year cross section (2008–2011), we identified 169...

10.1161/circulationaha.113.005757 article EN Circulation 2013-11-06

Data are lacking on the comparative effectiveness of commonly used glucose-lowering medications, when added to metformin, with respect microvascular and cardiovascular disease outcomes in persons type 2 diabetes.

10.1056/nejmoa2200436 article EN New England Journal of Medicine 2022-09-21

In a combined sample of more than 2600 smokers, immediate postcessation craving is shown to be prospectively associated with smokers' ability maintain abstinence. Relapse strikingly rapid among those reporting high levels following cessation. More 32% scores relapsed within 1 week contrast, fewer 15% low in the first (p < .001). Our findings provide warrant for an increased research effort designed better understanding factors that control smoking cessation and processes by which influences relapse.

10.1037//1064-1297.5.2.137 article EN Experimental and Clinical Psychopharmacology 1997-01-01
Coming Soon ...